Target intelligence / Profile preview

WASH and IL9R antisense RNA 2 (WASIR2)

Target
WASIR2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

WASH and IL9R antisense RNA 2 (WASIR2) is a long non-coding RNA transcribed antisense to regions involving the WASH and IL9R genes. As with other lncRNAs, WASIR2 is presumed to regulate gene expression at the transcriptional or post-transcriptional level, potentially by acting as a scaffold for protein complexes, influencing chromatin states, or modulating the activity of transcription factors via antisense mechanisms. The molecule is non-protein coding and is not confirmed as a drug target, receptor, enzyme, or transporter. No direct roles in disease, drug interactions, or utility as a biomarker have been reported, reflecting the limited characterization in current literature. The general functions of lncRNAs include cell differentiation, chromatin modification, and gene expression control, but specific functions for WASIR2 are not available in the cited sources. Based on the available evidence, WASIR2 falls within the category of lncRNAs that have regulatory roles without direct therapeutic targeting, and limited functional or disease relevance has been described at this time.

Other names
NCRNA00286AWASH and IL9R antisense RNA 2 (non-protein coding)non-protein coding RNA 286AWASIR2
02

Mechanism of action

Not applicable for drugs; lncRNAs may act by scaffolding protein complexes or regulating transcription through RNA-DNA or RNA-protein interactions

03

Biological functions

Putative regulation of gene expressionmay participate in transcriptional regulation and chromatin modification processes, as is common among lncRNAs and antisense RNAs
04

Disease associations

No direct disease associations or documented pathological roleslong non-coding RNAs in general can be involved in various diseases, but there is no evidence specific to WASIR2
05

Safety considerations

Not applicable; no direct therapeutic targeting or safety data
06

Interacting drugs

None reported
07

Biomarkers

None reported

Beyond the preview

Go deeper on WASH and IL9R antisense RNA 2 (WASIR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WASH and IL9R antisense RNA 2 (WASIR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call